Edwards Lifesciences Wins FDA Approval for PASCAL System
The FDA approved Edwards Lifesciences’ PASCAL Precision System for tricuspid valve repair, offering a new treatment option for certain patients with severe tricuspid regurgitation.
WASHINGTON (dpa-AFX) - Edwards Lifesciences (EW) announced that the U.S. FDA has approved the PASCAL Precision System for tricuspid valve repair, providing a new treatment option for certain patients with severe tricuspid regurgitation.The approval expands Edwards' portfolio of minimally invasive h…